| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 149, 903-910, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
Z Pan, W Radding, T Zhou, E Hunter, J Mountz and JM McDonald
Department of Pathology, University of Alabama at Birmingham 35294- 0007, USA.
The recently demonstrated extraordinary rate of turnover of T cells in human immunodeficiency virus (HIV)-1-infected patients and the apparently concomitant high rate of viral production and death are consistent with a large amount of cell death directly due to infection. Apoptosis may be one of the major forms of T cell death in HIV-1 infection. Many apoptotic pathways depend on calcium and therefore would be expected to involve calmodulin. As the HIV-1 envelope glycoprotein, gp160, contains two known calmodulin-binding domains, we investigated the possibility that the cytoplasmic domain of the HIV-1 envelope protein gp160 could enhance Fas-mediated apoptosis, the major form of apoptosis in lymphocytes. Our studies have shown that 1) transfection of H9 and MOLT-4 cells with a non-infectious HIV proviral clone, pFN, which expresses wild-type gp160, leads to enhanced Fas- mediated apoptosis, 2) transfection of MOLT-4 cells with a pFN construct pFN delta 147, which expresses a carboxyl-terminally truncated gp160 lacking the calmodulin-binding domains, produces less Fas-mediated apoptosis than transfection with pFN, and 3) the calmodulin antagonists trifluoperazine and tamoxifen completely inhibit the pFN enhancement of Fas-mediated apoptosis in MOLT-4 cells. We have replicated all of these results using the vectors pSRHS and pSRHS delta 147, which express wild-type gp160 and truncated gp160, respectively, in the absence of other viral proteins. These investigations provide a mechanism by which HIV-1 may induce apoptosis and a possible intracellular target for future therapeutics.
This article has been cited by other articles:
![]() |
B. L. Shacklett, K. E. S. Shaw, L. A. Adamson, D. T. Wilkens, C. A. Cox, D. C. Montefiori, M. B. Gardner, P. Sonigo, and P. A. Luciw Live, Attenuated Simian Immunodeficiency Virus SIVmac-M4, with Point Mutations in the Env Transmembrane Protein Intracytoplasmic Domain, Provides Partial Protection from Mucosal Challenge with Pathogenic SIVmac251 J. Virol., October 11, 2002; 76(22): 11365 - 11378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Lee, C.-Y. Ko, C.-T. Wang, and S. S.-L. Chen Effect of Point Mutations in the N Terminus of the Lentivirus Lytic Peptide-1 Sequence of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 on Env Stability J. Biol. Chem., May 3, 2002; 277(18): 15363 - 15375. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lenardo, S. B. Angleman, V. Bounkeua, J. Dimas, M. G. Duvall, M. B. Graubard, F. Hornung, M. C. Selkirk, C. K. Speirs, C. Trageser, et al. Cytopathic Killing of Peripheral Blood CD4+ T Lymphocytes by Human Immunodeficiency Virus Type 1 Appears Necrotic rather than Apoptotic and Does Not Require env J. Virol., April 16, 2002; 76(10): 5082 - 5093. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sasaki, K. Miyazaki, Y. Koga, G. Kimura, K. Nomoto, and H. Yoshida Calcineurin-Dependent Mitochondrial Disturbances in Calcium-Induced Apoptosis of Human Immunodeficiency Virus gp160-Expressing CD4+ Cells J. Virol., January 1, 2002; 76(1): 416 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clarke, F. Leonessa, J. N. Welch, and T. C. Skaar Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance Pharmacol. Rev., March 1, 2001; 53(1): 25 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Shacklett, C. J. Weber, K. E. S. Shaw, E. M. Keddie, M. B. Gardner, P. Sonigo, and P. A. Luciw The Intracytoplasmic Domain of the Env Transmembrane Protein Is a Locus for Attenuation of Simian Immunodeficiency Virus SIVmac in Rhesus Macaques J. Virol., July 1, 2000; 74(13): 5836 - 5844. [Abstract] [Full Text] |
||||
![]() |
K. J. Micoli, G. Pan, Y. Wu, J. P. Williams, W. J. Cook, and J. M. McDonald Requirement of Calmodulin Binding by HIV-1 gp160 for Enhanced FAS-mediated Apoptosis J. Biol. Chem., January 14, 2000; 275(2): 1233 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Pan, S. M. Vickers, A. Pickens, J. O. Phillips, W. Ying, J. A. Thompson, G. P. Siegal, and J. M. McDonald Apoptosis and Tumorigenesis in Human Cholangiocarcinoma Cells : Involvement of Fas/APO-1 (CD95) and Calmodulin Am. J. Pathol., July 1, 1999; 155(1): 193 - 203. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |